ChemComm
Communication
must be compatible with all of the enzymes) and possible inter-
ference of assay components. For example, in assays that include co-
factor proteins (e.g., formin and profilin in the case examined here)
and in the widely utilized application of inhibitor screening, the
effect of these additional components on the secondary (or
tertiary) enzyme activity cannot be ignored.21
Our results clearly demonstrate that using 1H NMR spectro-
scopy to measure ATPase activity is a sensitive and highly
automated approach. The method does not require antibodies,
secondary enzymes or additional reagents, affords a medium
throughput and can be employed under a variety of experimental
conditions. Because of the absence of additional reagents and
complex reactions, the assay is easily accessible to laboratories
that do not routinely engage with ATPase/kinase assays. The
range of ATP concentrations that can be utilized in the assay is
comparable to those employed in malachite green or LDH/PK
assays (micromolar to millimolar).22–24 These factors along with
the possible automation of data acquisition make this method
ideal for medium-throughput screening for inhibitors of ATP
and GTP dependent enzymes.
Fig. 3 Quantitative measurement of GTP/GDP in control experiment.
(a) GTP, GDP structure: the H8 used for quantification is labeled. (b) NMR
titration experiment to quantify GTP% in control samples. (c) Data fitting and
R2 analysis of control experiment.
Notes and references
1 J. R. Knowles, Annu. Rev. Biochem., 1980, 49, 877–919.
2 R. M. Eglen and T. Reisine, Assay Drug Dev. Technol., 2009, 7, 22–43.
3 T. P. Geladopoulos, T. G. Sotiroudis and A. E. Evangelopoulos, Anal.
Biochem., 1991, 192, 112–116.
4 N. W. Charter, L. Kauffman, R. Singh and R. M. Eglen,
J. Biomol. Screening, 2006, 11, 390–399.
5 M. A. Kashem, R. M. Nelson, J. D. Yingling, S. S. Pullen,
A. S. Prokopowicz 3rd, J. W. Jones, J. P. Wolak, G. R. Rogers,
M. M. Morelock, R. J. Snow, C. A. Homon and S. Jakes, J. Biomol.
Screening, 2007, 12, 70–83.
6 N. Hardt, S. M. Hacker and A. Marx, Org. Biomol. Chem., 2013, 11,
8298–8305.
7 J. G. Sheldon, S. P. Williams, A. M. Fulton and K. M. Brindle, Proc.
Natl. Acad. Sci. U. S. A., 1996, 93, 6399–6404.
8 G. J. Kemp, C. H. Thompson, P. R. J. Barnes and G. K. Radda, Magn.
Reson. Med., 1994, 31, 248–258.
9 J. A. Bittl, J. A. Balschi and J. S. Ingwall, Circ. Res., 1987, 60, 871–878.
10 D. Pucar, P. P. Dzeja, P. Bast, R. J. Gumina, C. Drahl, L. Lim,
N. Juranic, S. Macura and A. Terzic, Mol. Cell. Biochem., 2004,
256–257, 281–289.
NMR facility) equipped with a room temperature, inverse TBI probe.
We verified that peak resolution is still sufficient for accurate
integration of the ATP/ADP signals (Fig. S1a, ESI†), with high
reproducibility on five independent measurements acquired in
automation on the same sample. The lower detection limit under
the condition tested is approximately 300 nM ATP (Fig. S1b, ESI†).
Traditional methods to measure ATPase or kinase activity rely on
the measurement of ADP formation, ATP depletion or phospho-
product formation, with detection achieved by radiometric assays,
fluorescence, luminescence or colorimetric methods.15,16 Radio-
isotopes assays are associated with high costs and strict regulations.
The widely utilized assays that measure inorganic phosphates (Pi)
formation (e.g., the Malachite Green assay17), are hampered by the
high background signal of contaminating Pi (for example from
buffers and commercial ATP sources) or interference from buffer
components such as glycerol.18 This can be particularly problematic
when commercial sources of enzymes are utilized,19 when multiple
11 W. Kabsch and J. Vandekerckhove, Annu. Rev. Biophys. Biomol.
Struct., 1992, 21, 49–76.
protein components are present, like in the actin case examined 12 J. W. Shaevitz and Z. Gitai, Cold Spring Harbor Perspect. Biol., 2010,
2, a000364.
here, and when GTP hydrolysis is monitored, as it is reported to
13 F. B. Straub and G. Feuer, Biochim. Biophys. Acta, 1950, 4, 455–470.
14 V. Ramabhadran, A. L. Hatch and H. N. Higgs, J. Biol. Chem., 2013,
generate a higher background.20 The NMR-based assay demon-
strated here is insensitive to contaminating Pi, as it relies on the
simultaneous determination of ATP, ADP and AMP and is compa-
tible with a wide variety of buffer systems. No additional reagents or
288, 26847–26855.
15 Y. Jia, C. M. Quinn, S. Kwak and R. V. Talanian, Curr. Drug Discovery
Technol., 2008, 5, 59–69.
16 Z. L. Wu, PLoS One, 2011, 6, e23172.
incubation times are required and the experiment time is limited to 17 K. Itaya and M. Ui, Clin. Chim. Acta, 1966, 14, 361–366.
18 Y. Shirasaka, Y. Onishi, A. Sakurai, H. Nakagawa, T. Ishikawa and
S. Yamashita, Biol. Pharm. Bull., 2006, 29, 2465–2471.
19 M. Bartolini, I. W. Wainer, C. Bertucci and V. Andrisano, J. Pharm.
the effective NMR data acquisition time. The detection of ATP, ADP
and AMP strengthens the reliability and specificity of the method
and widens the applicability range. Furthermore, the NMR based
assay does not rely on the activity of coupled enzymes for the
detection of ADP accumulation. Assays like the pyruvate kinase
(PK) L-lactate dehydrogenase (LDH) linked assay offer the advantage
of a spectrophotometric measurement of NADH absorbance as ADP
is recycled to ATP, at the expense of increased complexity. The assay
Biomed. Anal., 2013, 73, 77–81.
20 C. A. Monroy, D. I. Mackie and D. L. Roman, PLoS One, 2013,
8, e62247.
21 K. Kiianitsa, J. A. Solinger and W.-D. Heyer, Anal. Biochem., 2003,
321, 266–271.
22 T. G. Huang and D. D. Hackney, J. Biol. Chem., 1994, 269,
16493–16501.
23 N. Harmel and H.-J. Apell, J. Gen. Physiol., 2006, 128, 103–118.
outcome is affected by limitations in the buffer choices (the buffer 24 K. Nadeau, A. Das and C. T. Walsh, J. Biol. Chem., 1993, 268, 1479–1487.
This journal is ©The Royal Society of Chemistry 2014
Chem. Commun., 2014, 50, 12037--12039 | 12039